Literature DB >> 7722552

Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities.

M S Eberhardt1, D T Lackland, F C Wheeler, R R German, S M Teutsch.   

Abstract

To consider the relationship between race and long-term glycemic control, as measured by glycosylated hemoglobin (GHb), we analyzed data from a community-based sample of 3175 adults in the South Carolina Cardiovascular Disease Prevention Project. A clinically meaningful difference for mean GHb levels (10.5 vs 8.4%, P < 0.001) was present between black people and white people reporting diabetes. Similarly, a significant association between race and GHb was present among people reporting "borderline diabetes" or no diabetes. Logistic regression confirmed this finding in all three diabetic categories, however, controlling for insulin use in the diabetic group reduced (P < 0.001) the association between GHb and race. These findings confirm that further improvements in glycemic control are necessary, especially for black patients and that black people not reporting diabetes have higher GHb levels compared to white people, possibly due to undiagnosed diabetes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7722552     DOI: 10.1016/0895-4356(94)90105-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  9 in total

Review 1.  Do race and ethnicity impact hemoglobin A1c independent of glycemia?

Authors:  William H Herman
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

2.  Implications of the new definition of diabetes for health disparities.

Authors:  Anusha M Vable; Melinda L Drum; Hui Tang; Marshall H Chin; Stacy T Lindau; Elbert S Huang
Journal:  J Natl Med Assoc       Date:  2011-03       Impact factor: 1.798

Review 3.  Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis.

Authors:  Julienne K Kirk; Ralph B D'Agostino; Ronny A Bell; Leah V Passmore; Denise E Bonds; Andrew J Karter; K M Venkat Narayan
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

4.  Pounds off with empowerment (POWER): a clinical trial of weight management strategies for black and white adults with diabetes who live in medically underserved rural communities.

Authors:  Elizabeth J Mayer-Davis; Angela M D'Antonio; Sharon M Smith; Gregory Kirkner; Sarah Levin Martin; Deborah Parra-Medina; Richard Schultz
Journal:  Am J Public Health       Date:  2004-10       Impact factor: 9.308

5.  Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.

Authors:  William H Herman; Yong Ma; Gabriel Uwaifo; Steven Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

6.  Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes.

Authors:  G Argyropoulos; A M Brown; S M Willi; J Zhu; Y He; M Reitman; S M Gevao; I Spruill; W T Garvey
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

Review 7.  Identifying Prediabetes and Type 2 Diabetes in Asymptomatic Youth: Should HbA1c Be Used as a Diagnostic Approach?

Authors:  Mary Ellen Vajravelu; Joyce M Lee
Journal:  Curr Diab Rep       Date:  2018-06-04       Impact factor: 4.810

8.  Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study.

Authors:  Stephen R Benoit; Regina Fleming; Athena Philis-Tsimikas; Ming Ji
Journal:  BMC Public Health       Date:  2005-04-17       Impact factor: 3.295

9.  Glycaemic control for people with type 2 diabetes in Saudi Arabia - an urgent need for a review of management plan.

Authors:  Mohammed J Alramadan; Dianna J Magliano; Turky H Almigbal; Mohammed Ali Batais; Afsana Afroz; Hesham J Alramadhan; Waad Faozi Mahfoud; Adel Mehmas Alragas; Baki Billah
Journal:  BMC Endocr Disord       Date:  2018-09-10       Impact factor: 2.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.